Last $49.60 USD
Change Today -0.05 / -0.10%
Volume 1.7M
CTRX On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ GS
Berlin
As of 8:10 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

catamaran corp (CTRX) Key Developments

Catamaran Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year 2015

Catamaran Corporation reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company's revenue was $5,739,890,000 compared to $4,528,800,000 a year ago. Operating income was $169,106,000 compared to $126,110,000 a year ago. Income before income taxes was $152,899,000 compared to $115,457,000 a year ago. Net income was $113,824,000 compared to $87,670,000 a year ago. Net income attributable to the Company was $100,448,000 compared to $74,403,000 a year ago. Diluted earnings per share attributable to the company was $0.48 compared to $0.36 a year ago. Net cash provided by operating activities was $163,045,000 compared to $139,542,000 a year ago. Purchases of property and equipment was $31,869,000 compared to $35,571,000 a year ago. EBITDA was $221,818,000 compared to $181,969,000 a year ago. Non-GAAP net income attributable to the Company was $138,423,000 compared to $116,773,000 a year ago. Non-GAAP diluted earnings per share attributable to the company was $0.67 compared to $0.56 a year ago. For the year, the company's revenue was $21,581,890,000 compared to $14,780,094,000 a year ago. Operating income was $568,996,000 compared to $443,768,000 a year ago. Income before income taxes was $507,908,000 compared to $402,142,000 a year ago. Net income was $373,722,000 compared to $298,739,000 a year ago. Net income attributable to the Company was $317,293,000 compared to $262,170,000 a year ago. Diluted Earnings per share attributable to the Company was $1.53 compared to $1.27 a year ago. Net cash provided by operating activities was $590,181,000 compared to $475,421,000 a year ago. Purchases of property and equipment was $78,078,000 compared to $128,842,000 a year ago. EBITDA was $786,876,000 compared to $651,096,000 a year ago. Non-GAAP net income attributable to the Company was $474,223,000 compared to $413,142,000 a year ago. Non-GAAP diluted earnings per share attributable to the company was $2.28 compared to $2.00 a year ago. Net income and EPS attributable to the Company increased during both periods due to increased revenue as a result of new customer implementations and additional income generated as a result of the Restat acquisition. These positive impacts to net income attributable to the Company were offset by an increase in operating expenses as discussed above, plus an increase in interest expense. The EBITDA growth was primarily due to increased net income attributable to the Company as a result of increased revenue, as noted previously. This was partially offset by increased costs incurred to support the Company's business growth. Cash from operating activities increased during both periods mainly due to an increase in net income. For the year 2015, the company has set the full year financial targets, which do not include any impact from the proposed acquisition of Healthcare Solutions. The company expects revenue of $23.5 billion to $24.5 billion, EBITDA of $905 million to $930 million, GAAP EPS (fully-diluted) of $1.77 to $1.92 and adjusted EPS (fully-diluted) of $2.45 to $2.60 (excluding all amortization of intangible assets). Depreciation in the range of $65 million to $70 million. Tax rate to increase to 30% to 32%, which is more consistent with historical averages. The company also expects to generate more than $600 million in cash flow from operations and expect CapEx to be relatively flat to 2014.

Catamaran Seeks Acquisitions

Catamaran Corporation (TSX:CCT) continues to manage robust pipeline of acquisition opportunities that complement core competencies and strengthen market position in important segments.

Catamaran Corporation, Q4 2014 Earnings Call, Feb 26, 2015

Catamaran Corporation, Q4 2014 Earnings Call, Feb 26, 2015

Catamaran Corporation to Report Q4, 2014 Results on Feb 26, 2015

Catamaran Corporation announced that they will report Q4, 2014 results at 6:00 AM, US Eastern Standard Time on Feb 26, 2015

Catamaran Corp. Introduces Innovative Clinical Outcomes-Based Program for Hepatitis C Treatment

Catamaran Corp. announced that it is introducing a new clinical outcomes-based program for hepatitis C treatment through its specialty pharmacy, BriovaRx. This new program will provide clients of Catamaran and BriovaRx an innovative new approach to hepatitis C treatment. Centered on producing positive health outcomes, the program will allow for overall treatment costs to take into account clinical results. Patients will be monitored during their entire treatment regimen through their participation in BriovaRx's Hepatitis C Patient Management Program in order to support full adherence.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CTRX:US $49.60 USD -0.05

CTRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Anthem Inc $146.85 USD +0.30
BioScrip Inc $5.21 USD -0.005
Cigna Corp $122.51 USD +0.65
Express Scripts Holding Co $84.28 USD -0.55
Walgreens Boots Alliance Inc $83.20 USD +0.18
View Industry Companies
 

Industry Analysis

CTRX

Industry Average

Valuation CTRX Industry Range
Price/Earnings 32.5x
Price/Sales 0.5x
Price/Book 2.0x
Price/Cash Flow 17.5x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CATAMARAN CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.